HRT Financial’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

HRT Financial’s Portfolio GHSI Stock Details GHSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,579	Closed	-$64K	–	3490
2024 Q3	$64K	Buy	+11,579	New	+$117K	﹤0.01%	2084
2023 Q1	–	Sell	-440	Closed	-$3K	–	3349
2022 Q4	$3K	Buy	+440	New	+$3.52K	﹤0.01%	2312
2022 Q2	–	Sell	-848	Closed	-$9K	–	3908
2022 Q1	$9K	Buy	+848	New	+$17.2K	﹤0.01%	2910
2021 Q1	–	Sell	-61	Closed	-$7K	–	3265
2020 Q4	$7K	Buy	+61	New	+$4.26K	﹤0.01%	1765
2020 Q1	–	Sell	-35	Closed	-$2K	–	1453
2019 Q4	$2K	Sell	35 -7	-17%	-$668	﹤0.01%	1100
2019 Q3	$9K	Buy	+42	New	+$9.51K	﹤0.01%	1355

HRT Financial's GHSI Position: Q4 2024 in Review

HRT Financial sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2024, closing a stake of 11,579 shares — an estimated $64K sold.

HRT Financial first reported a position in GHSI in Q3 2019 and held it in 6 quarters. The position peaked at $64K in Q3 2024. 0 funds tracked by Wall St. Rank hold GHSI as of Q4 2024.

HRT Financial reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 11,579 Guardion Health Sciences, Inc. Common Stock shares in Q4 2024, an estimated $64K.
HRT Financial first reported a position in Guardion Health Sciences, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
HRT Financial's Guardion Health Sciences, Inc. Common Stock position peaked at $64K in Q3 2024.
0 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.